PKA Inhibitors

PKA

PKAR

PKACα

PKA Inhibitors, Agonists & Activators

Product Name	PKA	PKAR	PKACα	Purity
Bucladesine sodium	PKA			99.36%
Fasudil Hydrochloride	PKA, IC₅₀: 4.58 μM			99.97%
KT5823	PKA, Ki: 10 μM			99.90%
Bucladesine hemicalcium	PKA			98.58%
Fasudil	PKA, IC₅₀: 4.58 μM			99.98%
Daphnetin	PKA, IC₅₀: 9.33 μM			99.77%
Bilobetin	PKA			99.71%
PKA Inhibitor Fragment (6-22) amide TFA	PKA, Ki: 2.8 nM			99.77%
AT13148	PKA, IC₅₀: 3 nM			99.20%
AT7867	PKA, IC₅₀: 20 nM			99.85%
CW 008	PKA			98.15%
ML281	PKA			98.04%
Sp-cAMPS sodium salt	PKA I PKA II			99.45%
AT7867 dihydrochloride	PKA, IC₅₀: 20 nM			99.73%
6-Bnz-cAMP sodium salt	PKA			98.5%
Hu7691	PKA, IC₅₀: 11 nM			99.91%
PKC-IN-6	PKA, IC₅₀: >500 μM			99.93%
Jaspamycin	Trypanosoma brucei PKA holoenzyme, Kd: 8 nM	Trypanosoma brucei PKAR(199-499), EC₅₀: 6.5 nM		98.94%
Undecane	PKA			99.66%
PKA Inhibitor Fragment (6-22) amide	PKA, Ki: 2.8 nM			98.00%
Sp-8-Br-cAMPS sodium	PKA, EC₅₀: 360 nM			99.9%
Sp-cAMPS	PKA I PKA II
PF-4950834	PKA, IC₅₀: 424 nM			99.60%
Fasudil dihydrochloride	PKA, IC₅₀: 4.58 μM			99.98%
Akt1&PKA-IN-1	PKAa, IC₅₀: 0.03 μM
A-3 hydrochloride	PKA, Ki: 4.3 μM			99.75%
β-Patchoulene	PKA
Hu7691 free base	PKA, IC₅₀: 11 nM
Fasudil hydrochloride semihydrate	PKA, IC₅₀: 4.58 μM
Sp-cAMPS triethylamine	PKA I PKA II
HA-100 hydrochloride	PKA, IC₅₀: 8 μM
PKA-IN-2			J-PKACα, IC₅₀: 6.3 nM
GSK-3α/β-IN-1	PKA, IC₅₀: 0.188 μM
HA-100 dihydrochloride	PKA, IC₅₀: 8 μM
GSK466317A	PKA, IC₅₀: 12.59 μM
Balanol	PKA
LX7101 monohydrochloride	PKA, IC₅₀: <1 nM

Name
Email *

	Sorry, but the email address you supplied was invalid.